Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12318454
Bicyclic peptide ligands specific for MT1-MMP
granted -
US 12318418
Modified adenoviruses
granted -
US 12318397
Methods and compositions for testosterone production
granted -
US 12318386
Combination of XPO1 inhibitors and second agents for the treatment of prostate cancer
granted -
US 12319929
Compositions and methods for the treatment of Parkinson's disease
granted -
US 12318356
Use of cannabinoids in the treatment of epilepsy
granted -
US 12318376
Compositions of a polyorthoester and an aprotic solvent
granted -
US 12318364
Isoflavonoid compositions and methods for the treatment of cancer
granted -
US 12318426
Compositions and methods for the treatment of metabolic and liver disorders
granted -
US 12318401
Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy
granted -
US 12318413
Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome
granted -
US 12317874
Method of using a genetically modified mouse that expresses human albumin
granted -
US 12318487
Solid tablet dosage form of ridinilazole
granted -
US 12318457
Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof
granted -
US 12319724
IL2 agonists and methods of use thereof
granted -
US 12318375
Method of treatment with tradipitant
granted -
US 12319703
Macrocyclic fused pyrazoles as Mcl-1 inhibitors
granted -
US 12319738
Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer
granted -
US 12318362
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 12319940
Methods for purification of arylsulfatase A
granted -
WO 2025111409
COMPOSÉS HÉTÉROCYCLIQUES DE FORMULE (I) DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE L'AMYOTROPHIE SPINALE PAR MODULATION DE L'ÉPISSAGE DE SMN2
granted -
WO 2025108443
COMPOSÉS HÉTÉROCYCLIQUES ET COMPOSITIONS ASSOCIÉES, ET MÉTHODES DE TRAITEMENT CORRESPONDANTES
granted -
WO 2025111258
COMPOSITIONS DE SÉROTYPE A DE NEUROTOXINE DE CLOSTRIDIUM BOTULINUM ET PROCÉDÉS DE FILTRATION AMÉLIORÉS
granted -
WO 2025111408
COMPOSÉS POUR LE TRAITEMENT DE L'AMYOTROPHIE SPINALE ET DE LA MALADIE DE HUNTINGTON
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.